| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA775: Dapagliflozin for treating chronic kidney disease |
|
Medicine details |
|
| Medicine name | dapagliflozin (Forxiga®) |
| Formulation | 5mg, 10mg film coated tablets |
| Reference number | 3658 |
| Indication | Treatment of chronic kidney disease |
| Company | AstraZeneca UK Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 30/07/2021 |
| NICE guidance | |